<DOC>
	<DOC>NCT02102295</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of a dentifrice containing L-ascorbic acid 2-phosphate magnesium salt on gingival inflammation, gingival bleeding and gingival redness.</brief_summary>
	<brief_title>Effects of Antioxidant Dentifrice on Gingivitis</brief_title>
	<detailed_description />
	<mesh_term>Gingivitis</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<mesh_term>Ascorbate-2-phosphate</mesh_term>
	<criteria>Age between ≥ 20 and &lt; 65 y with at least 16 permanent teeth. Gingival inflammation or mean baseline GI ≥ 0.5 without severe periodontal disease enough to require professional therapy. Written informed consent to participate. Taking medications that could influence periodontal tissue health, such as antimicrobials and antihypertensives within 1 month before starting the trial. Use of orthodontic appliances. Pregnancy or planning to become pregnant during the trial period. Previous participation in any other clinical trial. Inability of patient to understand the study purpose and/or study protocols. Judged unsuitable by investigators for other reasons.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Gingivitis</keyword>
	<keyword>antioxidant</keyword>
	<keyword>dentifrice</keyword>
	<keyword>Ascorbic Acid Derivative</keyword>
	<keyword>L ascorbic acid 2 phosphate magnesium salt</keyword>
</DOC>